At the intersection of artificial intelligence and oncology, Dana-Farber Cancer Institute and NYU Langone Health have launched Solavia Decision Suite — a platform that embeds decades of specialized cancer treatment knowledge directly into the electronic health records clinicians use at the moment of decision. The system addresses one of modern medicine's quiet crises: the widening distance between what leading research institutions know and what individual clinicians can reasonably access. In making institutional expertise portable and scalable, Solavia asks a deeper question about the future